Ming Zhao M.D.
Associate Professor of the Department of Medical Imaging
& Interventional Radiology, Sun Yat-Sen University Cancer Center

Dr. Zhao received his M.D. in Clinic Medical Department from Ben-Bu medical school in An Hui Province in 1993. He worked as resident doctor and completed his residence training course in the Internal Medicine at first Affiliated Hospital of Ben-Bu Medical School from 1993-1997. He completed continuing education courses of image diagnosis and interventional treatment in Sun Yat-Sen University of Medical Science (SUMS) from 1997 to 2000 and continuously finish his residence training course of imagine diagnosis and interventional treatment from 2000-2001. From 2002-2006, he completed continuing education courses of imagine-guiding minimally interventional treatment in Sun Yat-Sen University. Now he is Associate Professor working in the Cancer Center of Interventional District.
In the clinical practice, his primary interest is management of primary and secondary liver tumors with minimally invasive procedure. He use arterial infusion, chemoembolization to management the primary and metastatic liver, lung tumor et al; he also can use radiofreqency ablation (under the imagine such as CT-guide) to treat the solid tumor, for the minimally invasive procedure (radiofreqency ablation, 125I-seeding-implantation) is safety, efficiency, quickly recovery and become a standard first-line treatment to some solid tumor at present, especially for the poor-condition patients and refuse establishment treatment. In palliative treatment, the minimally invasive also has it advantage to relief patient illness and it is also as salvage treatment in many kind of condition.
As a famous Chinese cancer center is the national anti-tumor drug evaluation center, He also tries to use some new drugs in treatment of liver cancer (Phase 11 clinic trials of TACE combined with Sorafenib in the treatment of hepatocellular carcinoma). He has learned a lot of about planning, designing, analyzing of clinical trial. Other than these works, He had applied for two province grants concerned about the treatment of HCC. He had published more the twentieths articles in this field.

Publications:
1. Safety of perfused needle electrode radiofrequency ablation in the first and second portal region parenchyma in swine. Chinese Journal of Cancer 2007, Vol. 26. No11:1194-1198
2. Peri-gallbladder and colon wall tissue necrosis after hepatic radiofrequency ablation. Journal of Sun Yat-Sen University (Medical sciences). 2007,Vol.28.No.6:666-669
3. Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial. National Medical Journal of China, 2006, Vol.86. No.26:1823-1828
4. Advantage of 18FDG-PET/CT in Surveillance and Guiding of Patients with Hepatocellular Carcinoma Treated with TACE Combined with RFA. Chinese Journal of Cancer 2005,Vol.24.No.9:1118-1123
5. Treatment of liver tumors with CT-guided percutaneous radio-frequency ablation in 92 cases-complications encountered and managed. Journal of Interventional Radiology, 2005, Vol.14. No.6: 599-602
6. Analysis of appearance of nodules primary hepatic carcinoma in CT scanning. Chinese Journal of Cancer, 2001,Vol.20.No .7: 940-941
7. The value of spiral CT in CT arterial portography and CT hepatic arteriography. Chinese Journal of Oncology. 1999, Vol.21.No. 6: 450-452
8. The clinical value of 18FDG PET/CT on interventional therapy of primary hepatocellular carcinomas. Journal of Interventional Radiology 2005, Vol.14. No. 6:588-591
9. Observation of therapeutic effect of solid tumor in lung after radiofrequency ablation. Chinese Journal of Radiology, 2002, Vol. 36.No.4:321-324
10. The Value of radiofrequency ablation in the treatment of malignant liver tumor. Chinese Journal of Radiology, 2002,Vol.36.No.4:313-316
11. The usefulness of hepatic spiral multi-phase CT scanning in diagnosis of multiple hemangioma and coincident with hepatocellular carcinoma or met static tumor of the liver. Chinese Journal of Cancer, 2000, Vol.19. No.2: 162-165
12. Analysis of CT appearance of the liver metastasis tumor of nasopharyngeal carcinoma. Chinese Journal of Cancer, 2000, Vol.19.No. 10: 940-941,
13. Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma. Chinese Journal of Cancer, 2006,Vol. 25.No.11: 1414-1418
14. CT guided radioactive seed ~ (125) I implantation in treatment of pancreatic cancer. National Medical Journal of China，2006,Vol.86.No.4:223-227
15. Evaluation of combined percutaneous radiofrequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma. Chinese Journal of Oncology 2005, Vol.27. No4:248-250
16. Observation TACE (Transecatheter arterial chemical embolization) combined with CT guide radiofrequency ablation treatment for advanced liver cancer. Chinese Journal of Radiology, 2003, Vol.37. No. 10:901-904
17. Compare the pharmacokinetics and adverse reaction in interventional and systemic chemotherapy of lung cancer. Journal of Imagine and Interventional Radiology, 2003，Vol. 12.No.1: 30-32

Address:
Department of Medical Imaging & Interventional Radiology, Cancer Center, Sun Yat-Sen University
65 l# Dong Feng Road, East
Guangzhou Guangdong P.R. CHINA 510060
Tel: 086-20-87343272
Fax: 086-20-87343272
E-mail: zhaoming_shch@Hotmail.com